Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs
Rights accessRestricted access - publisher's policy
PMLA nanoparticles with diameters of 150–250nm are prepared, and their hydrolytic degradation is studied under physiological conditions. Degradation occurs by hydrolysis of the side chain methyl ester followed by cleavage of the main-chain ester group with methanol and L-malic acid as the final degradation products. No alteration of the cell viability is found after 1 h of incubation, but toxicity increases significantly after 3 d, probably due to the noxious effect of the released methanol. Anticancer drugs temozolomide and doxorubicin are encapsulated in the NPs with 20–40% efficiency, and their release is monitored using in vitro essays. Temozolomide is fully liberated within several hours, whereas doxorubicin is steadily released from the particles over a period of 1 month.
CitationLanz, A. [et al.]. Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs. "Macromolecular bioscience", 10 Octubre 2011, vol. 11, núm. 10, p. 1370-1377.